Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Overview of immunosuppressive and conventional (non-biologic) disease-modifying drugs in the rheumatic diseases

Philip Seo, MD
Section Editor
Daniel E Furst, MD
Deputy Editor
Paul L Romain, MD


Immunosuppressive drugs other than glucocorticoids are used in the treatment of various rheumatologic conditions to achieve one or more of the following goals:

To induce or maintain a remission

To reduce the frequency of flare or relapse

To allow tapering of glucocorticoids while maintaining disease control

This topic review will provide an overview of the use of immunosuppressive drugs in various rheumatic diseases, including the conventional (non-biologic) disease-modifying antirheumatic drugs (DMARDs), sometimes referred to as traditional DMARDs. Detailed discussions concerning the use of these drugs in specific rheumatic disorders are presented in the appropriate topic reviews covering the treatment of each condition.

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Oct 24, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.